These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38153093)

  • 1. Targeted Mass Spectrometry Analyses of Somatic Mutations in Colorectal Cancer Specimens Using Differential Ion Mobility.
    Wu Z; Bonneil É; Belford M; Boeser C; Dunyach JJ; Thibault P
    J Proteome Res; 2024 Feb; 23(2):644-652. PubMed ID: 38153093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate Quantitative Proteomic Analyses Using Metabolic Labeling and High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS).
    Pfammatter S; Bonneil E; McManus FP; Thibault P
    J Proteome Res; 2019 May; 18(5):2129-2138. PubMed ID: 30919622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Differential Ion Mobility Device Expands the Depth of Proteome Coverage and the Sensitivity of Multiplex Proteomic Measurements.
    Pfammatter S; Bonneil E; McManus FP; Prasad S; Bailey DJ; Belford M; Dunyach JJ; Thibault P
    Mol Cell Proteomics; 2018 Oct; 17(10):2051-2067. PubMed ID: 30007914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations.
    Minegishi Y; Kiyotani K; Nemoto K; Inoue Y; Haga Y; Fujii R; Saichi N; Nagayama S; Ueda K
    Commun Biol; 2022 Aug; 5(1):831. PubMed ID: 35982173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-field asymmetric waveform ion mobility spectrometry for mass spectrometry-based proteomics.
    Swearingen KE; Moritz RL
    Expert Rev Proteomics; 2012 Oct; 9(5):505-17. PubMed ID: 23194268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional separation and analysis of alpha-1-acid glycoprotein N-glycopeptides using high-field asymmetric waveform ion mobility spectrometry (FAIMS) and nano-liquid chromatography tandem mass spectrometry.
    Chandler KB; Marrero Roche DE; Sackstein R
    Anal Bioanal Chem; 2023 Jan; 415(3):379-390. PubMed ID: 36401639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
    Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A
    Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.
    Gularte-Mérida R; Smith S; Bowman AS; da Cruz Paula A; Chatila W; Bielski CM; Vyas M; Borsu L; Zehir A; Martelotto LG; Shia J; Yaeger R; Fang F; Gardner R; Luo R; Schatz MC; Shen R; Weigelt B; Sánchez-Vega F; Reis-Filho JS; Hechtman JF
    JCO Precis Oncol; 2022 Mar; 6():e2100365. PubMed ID: 35235413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.
    Benmokhtar S; Laraqui A; El Boukhrissi F; Hilali F; Bajjou T; Jafari M; El Zaitouni S; Baba W; El Mchichi B; Elannaz H; Lahlou IA; Chahdi H; Oukabli M; Mahfoud T; Tanz R; Ichou M; Ennibi K; Dakka N; Sekhsokh Y
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3725-3733. PubMed ID: 36444585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS and BRAF mutations in Serbian patients with colorectal cancer.
    Jakovljevic K; Malisic E; Cavic M; Krivokuca A; Dobricic J; Jankovic R
    J BUON; 2012; 17(3):575-80. PubMed ID: 23033302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Thyreostatic Drug Detection in Animal Tissues Using Liquid Chromatography-High-Field Asymmetric Waveform Ion Mobility Spectrometry-Mass Spectrometry.
    Purves RW; Souster K; West M; Huda AM; Fisher CME; Belford MW; Shurmer BO
    J Agric Food Chem; 2022 Apr; 70(16):4785-4791. PubMed ID: 35060701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
    BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of mass spectrometry performance for proteomic analyses using high-field asymmetric waveform ion mobility spectrometry (FAIMS).
    Bonneil E; Pfammatter S; Thibault P
    J Mass Spectrom; 2015 Nov; 50(11):1181-95. PubMed ID: 26505763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [KRAS and BRAF gene mutations in correlation with clinicopathologic features of colorectal carcinoma in Chinese].
    Zhu XL; Cai X; Zhang L; Yang F; Sheng WQ; Lu YM; Du X; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):584-9. PubMed ID: 23157824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
    Lewandowska MA; Jóźwicki W; Żurawski B
    Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Segmented Ion Fractionation and Differential Ion Mobility on a Q-Exactive Hybrid Quadrupole Orbitrap Mass Spectrometer.
    Pfammatter S; Wu Z; Bonneil E; Bailey DJ; Prasad S; Belford M; Rochon J; Picard P; Lacoursière J; Dunyach JJ; Thibault P
    Anal Chem; 2021 Jul; 93(28):9817-9825. PubMed ID: 34213903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.
    Zmrzljak UP; Košir R; Krivokapić Z; Radojković D; Nikolić A
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33669856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.
    Cushman-Vokoun AM; Stover DG; Zhao Z; Koehler EA; Berlin JD; Vnencak-Jones CL
    Clin Colorectal Cancer; 2013 Sep; 12(3):168-78. PubMed ID: 23773459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.